Quick Answer
Olema Pharmaceuticals, Inc. reported Stockholders Equity of $478.56 million for fiscal year 2025.
Olema Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $478.56M | +17.0% |
| 2024 | $408.96M | +61.1% |
| 2023 | $253.90M | +28.5% |
| 2022 | $197.55M | -30.6% |
| 2021 | $284.57M | -15.8% |
| 2020 | $338.14M | +3291.8% |
| 2019 | -$10.59M | -26.2% |
| 2018 | -$8.40M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $307.49M | +54.6% | -10.9% |
| June 30, 2025 | $345.24M | +52.0% | -10.0% |
| March 31, 2025 | $383.45M | +62.3% | -6.2% |
| December 31, 2024 | $408.96M | +61.1% | +105.6% |
| September 30, 2024 | $198.91M | -27.7% | -12.4% |
| June 30, 2024 | $227.16M | +40.6% | -3.9% |
| March 31, 2024 | $236.32M | +35.1% | -6.9% |
| December 31, 2023 | $253.90M | +28.5% | -7.7% |
- Olema Pharmaceuticals, Inc. showed an increase of +17.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Olema Pharmaceuticals, Inc.’s stockholders equity has grown by 5799.2% (from -$8.40 million to $478.56 million).
- The most recent figure is from Olema Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: